Trial Details
COMPLETEDBasic Information
| Clinical ID | c4716 |
|---|---|
| Identifier | NCT00072943 |
| Trial Title | A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Colitis|Intestinal Disease|Gastrointestinal Disease|Digestive System Disease |
| Interventions | DRUG: anti-Interferon-gamma monoclonal antibody |
Participant Information
| Sponsor | Facet Biotech |
|---|---|
| City | Anaheim |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2002-03 |
|---|---|
| Primary Completion Date | 2004-04 |
| Completion Date | 2004-04 |